Revolution Medicines, Inc.
RVMD
$99.00
$4.144.36%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -87.54% | -95.28% | -85.98% | -83.97% | -20.45% |
| Total Depreciation and Amortization | 49.08% | 56.69% | 38.70% | 38.69% | 20.68% |
| Total Amortization of Deferred Charges | -66.67% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 393.98% | 193.32% | 278.53% | 12,088.79% | -35.90% |
| Change in Net Operating Assets | -23.26% | 445.92% | 9.22% | 105.16% | 98.62% |
| Cash from Operations | -98.31% | -58.96% | -73.02% | -21.10% | -14.70% |
| Capital Expenditure | -57.53% | 4.86% | -210.55% | -3.13% | 47.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 119.61% | 257.10% | -62.19% | 94.82% | -3.60% |
| Cash from Investing | 119.06% | 215.74% | -68.25% | 93.57% | -3.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -53.03% | -94.63% | -12.30% | 10.12% | 30,461.63% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -99.80% | -- | -- | -- | -88.62% |
| Cash from Financing | -58.15% | -102.06% | 3,319.28% | 7.90% | 4.10% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -51.46% | -146.74% | 643.30% | 48.61% | 1.25% |